WeLeader Biomedical Co

WeLeader Biomedical Co Tangible Book Value per Share

The Tangible Book Value per Share of WeLeader Biomedical Co (7713.TWO) as of Oct 20, 2026 is 27.71 TWD. In the previous year, Tangible Book Value per Share was 19.89 TWD — a change of 39.33% (higher).

Tangible Book Value per Share

27.71TWD

YoY

39.33%

Last updated:

Tangible Book Value per Share of WeLeader Biomedical Co is 2025 27.71 TWD. Tangible Book Value per Share of WeLeader Biomedical Co was 2024 19.89 TWD. It decreases by 39.33% higher compared to the previous year.

The WeLeader Biomedical Co Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2020
5.79 TWD
Jan 1, 2021
7.72 TWD
Jan 1, 2022
14.08 TWD
Jan 1, 2023
18.51 TWD
Jan 1, 2024
19.89 TWD
Jan 1, 2025
27.71 TWD
The WeLeader Biomedical Co Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
27.71TWD+39.33%
19.89TWD+7.42%
18.51TWD+31.43%
14.08TWD+82.35%
7.72TWD+33.32%
5.79TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

WeLeader Biomedical Co Stock analysis

What does WeLeader Biomedical Co do? WeLeader Biomedical Co Ltd is a Taiwan-based company operating in the Health Care sector, specifically within Health Care Providers & Services. Headquartered in Kaohsiung, the company focuses on the agency and trading of in vitro diagnostic instruments and reagent-related products. It provides medical testing-related services, including distribution, after-sales, and maintenance for laboratory reagents, consumables, instruments, and equipment. Additionally, the company offers construction planning for medical testing laboratories, equipment procurement, operational coaching, and ancillary services such as human resources development and training. WeLeader Biomedical also develops digital medical examination platforms. The firm primarily serves the domestic market, with its products and services mainly sold within Taiwan. The company completed its initial public offering (IPO) on January 2, 2024, and is listed under the ticker symbol 7713.TWO with ISIN TW0007713000. Its website is https://www.weleader.com.tw/. The company operates in the health care industry, emphasizing diagnostic solutions and laboratory support services within Taiwan's medical infrastructure. WeLeader Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about WeLeader Biomedical Co stock

Tangible Book Value per Share of WeLeader Biomedical Co is 27.71 TWD in 2025.

Tangible Book Value per Share of WeLeader Biomedical Co changed from 19.89 TWD to 27.71 TWD, representing a 39.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share WeLeader Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — WeLeader Biomedical Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — WeLeader Biomedical Co